Company name FIL Limited
Headline Form 8.3 - ABBVIE INC


RNS Number : 8818F
FIL Limited
17 July 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

Company dealt in

ABBVIE INC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORDINARY SHARES

Date of dealing

16-JULY-2019

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


Long

Short


Number


(%)

Number


(%)

(1) Relevant securities

30,195,318                 2.04%


(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total

30,195,318                 2.04%


 

THE ABOVE INCLUDES A TRANSFER OUT OF 49,491 ORDINARY SHARES

 

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short


Number


(%)

Number


(%)

(1) Relevant securities



 

(2) Derivatives (other than options)



 

(3) Options and agreements to purchase/sell



Total




Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Sale

2,300

70.09 USD/UNIT

 

Sale

4,600

70.14 USD/UNIT

Purchase

36,162

69.25 USD/UNIT

Purchase

2,900

69.26 USD/UNIT

Purchase

9,300

69.28 USD/UNIT

Purchase

4,900

69.29 USD/UNIT

Purchase

5,729

69.34 USD/UNIT

Purchase

5,372

69.36 USD/UNIT

Purchase

10,008

69.38 USD/UNIT

Purchase

11,944

69.39 USD/UNIT

Purchase

1,600

69.41 USD/UNIT

Purchase

2,000

69.43 USD/UNIT

Purchase

21,580

69.45 USD/UNIT

Purchase

1,195

69.55 USD/UNIT

Purchase

20,123

69.63 USD/UNIT

Purchase

15,800

69.64 USD/UNIT

Purchase

4,370

69.65 USD/UNIT

Purchase

2,133

69.67 USD/UNIT

Purchase

1,700

69.68 USD/UNIT

Purchase

3,464

69.77 USD/UNIT

Purchase

388

69.79 USD/UNIT

Purchase

163

69.86 USD/UNIT

Purchase

2,700

69.88 USD/UNIT

Purchase

800

69.89 USD/UNIT

Purchase

1,829

69.90 USD/UNIT

Purchase

1,027

69.91 USD/UNIT

Purchase

200

69.92 USD/UNIT

Purchase

1,500

69.98 USD/UNIT

Purchase

1,185

69.99 USD/UNIT

Purchase

1,572

70.00 USD/UNIT

Purchase

749

70.02 USD/UNIT

Purchase

2,300

70.09 USD/UNIT

Purchase

6,200

70.10 USD/UNIT

Purchase

4,600

70.14 USD/UNIT

Sale

7,624

69.43 USD/UNIT

Purchase

2,869

69.67 USD/UNIT

Sale

23

69.99 USD/UNIT

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)





 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)








 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)




 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)




Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            NO

 

Date of disclosure

17-July-2019

Contact name

Paul Clark

Telephone number

00 353 1 223 1447

If a connected EFM, name of offeree/offeror with which connected


If a connected EFM, state nature of connection (Note 10)


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISECKODBQBKDBOD